Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

Similar articles for PubMed (Select 17449446)

1.

Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Green AI.

Neurotox Res. 2007 Jan;11(1):33-40. Review.

PMID:
17449446
2.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

Green AI.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7. Review.

PMID:
16961422
3.

Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R.

CNS Drugs. 2008;22(11):903-16. Review.

PMID:
18840032
4.

Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Noordsy DL, Green AI.

Curr Psychiatry Rep. 2003 Oct;5(5):340-6. Review.

PMID:
13678553
5.

Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

Green AI.

J Clin Psychiatry. 2005;66 Suppl 6:21-6. Review.

PMID:
16107180
6.

Treatment of schizophrenia and comorbid substance use disorder.

Green AI, Salomon MS, Brenner MJ, Rawlins K.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):129-39. Review.

PMID:
12769622
7.
8.

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.

Wobrock T, Soyka M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1375-85. doi: 10.1016/j.pnpbp.2008.02.008. Epub 2008 Feb 26. Review.

PMID:
18394768
9.

Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Roth RM, Brunette MF, Green AI.

Curr Psychiatry Rep. 2005 Aug;7(4):283-91. Review.

PMID:
16098282
10.
11.

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.

Scheller-Gilkey G, Woolwine BJ, Cooper I, Gay O, Moynes KA, Miller AH.

Am J Drug Alcohol Abuse. 2003 Aug;29(3):553-66.

PMID:
14510040
12.

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.

Zimmet SV, Strous RD, Burgess ES, Kohnstamm S, Green AI.

J Clin Psychopharmacol. 2000 Feb;20(1):94-8.

PMID:
10653215
13.

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

Drake RE, Xie H, McHugo GJ, Green AI.

Schizophr Bull. 2000;26(2):441-9.

14.

Management of schizophrenia with substance use disorders.

Lybrand J, Caroff S.

Psychiatr Clin North Am. 2009 Dec;32(4):821-33. doi: 10.1016/j.psc.2009.09.002. Review.

PMID:
19944886
15.

[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Wobrock T, D'Amelio R, Falkai P.

Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. Review. German.

PMID:
17619840
16.

Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.

San L, Arranz B, Martinez-Raga J.

Eur Addict Res. 2007;13(4):230-43. Review.

PMID:
17851245
17.

Management of substance use disorder in schizophrenia patients: current guidelines.

Drake RE.

CNS Spectr. 2007 Oct;12(10 Suppl 17):27-32. Review.

PMID:
17934387
18.

Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.

Mesholam-Gately RI, Gibson LE, Seidman LJ, Green AI.

Schizophr Res. 2014 May;155(1-3):45-51. doi: 10.1016/j.schres.2014.03.002. Epub 2014 Mar 29.

PMID:
24685823
19.

Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Green AI, Noordsy DL, Brunette MF, O'Keefe C.

J Subst Abuse Treat. 2008 Jan;34(1):61-71. Epub 2007 Jun 15. Review.

20.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk